YOLFTbeta
Jiangsu Nanfang Medical

Jiangsu Nanfang Medical

603880 · SHG · Healthcare / Medical Instruments & Supplies

7.18CNY-0.80 (-10.03%)

Price History

Full chart

Market Stats

Previous Close7.98
Open7.91
Day Range7.18 – 7.98
52-Week Range5.30 – 10.39
Volume14.29M
Market Cap2.44B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.37
Dividend Yield0.00%
Beta0.43
50-Day Avg8.46
200-Day Avg7.37

About

Jiangsu Nanfang Medical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of transdermal products, medical adhesive tapes and bandages, sports protective equipment, first aid kits, nitrile gloves, and protective equipment in China and internationally. The company offers medical proof fabrics, care products, band-aids, and applications; medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical eye pads, elastic stretch tapes, corn removal plasters, waterproof adhesive tapes, pain relief patches, kinesiology tapes, surgical tapes, zinc oxide adhesives, masks, and nitrile gloves; and customized products. It also provides medical devices, disinfectant products, personal protective equipment, and high-performance membrane materials. In addition, the company engages in equity investment and business management consulting activities. Jiangsu Nanfang Medical Co., Ltd. was founded in 1990 and is headquartered in Changzhou, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOYahua Wang
  • Employees789
  • HeadquartersNo. 1, Guoxiang Road, Changzhou, China, 213149, China
  • Websitehttps://www.nfmedical.com.cn

Leadership

  • Yahua WangAccounting Supervisor

Financials

Income Statement

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue424.62M510.80M469.80M433.02M444.24M488.71M479.82M491.69M1.07B527.44M545.37M600.10M602.62M600.51M
Growth (%)-+20.30%-8.03%-7.83%+2.59%+10.01%-1.82%+2.47%+118.11%-50.82%+3.40%+10.03%+0.42%-0.35%
Cost of Revenue320.62M378.94M336.94M301.23M316.08M361.24M373.15M388.94M722.59M432.92M477.73M566.33M631.53M577.08M
Gross Profit104.00M131.86M132.87M131.79M128.16M127.46M106.68M102.75M349.81M94.52M67.63M33.76M-28.91M23.43M
Gross Margin24.49%25.81%28.28%30.43%28.85%26.08%22.23%20.90%32.62%17.92%12.40%5.63%-4.80%3.90%
Operating Expense57.27M75.98M72.44M71.77M67.70M77.75M61.35M77.35M248.13M122.59M96.99M180.59M168.79M83.32M
Operating Income46.74M55.88M60.43M60.02M60.46M49.71M45.32M25.40M101.68M-28.07M-29.36M-146.82M-197.70M-59.89M
Operating Margin11.01%10.94%12.86%13.86%13.61%10.17%9.45%5.17%9.48%-5.32%-5.38%-24.47%-32.81%-9.97%
EBITDA53.71M79.44M76.21M76.02M80.76M68.62M62.60M47.50M137.91M10.23M32.56M-71.06M-124.39M-26.16M
EBITDA Margin12.65%15.55%16.22%17.56%18.18%14.04%13.05%9.66%12.86%1.94%5.97%-11.84%-20.64%-4.36%
Net Income35.77M48.04M53.38M51.24M51.98M47.60M39.25M28.05M98.07M-22.76M-14.65M-147.42M-190.67M-101.71M
Net Income Margin8.42%9.41%11.36%11.83%11.70%9.74%8.18%5.71%9.14%-4.32%-2.69%-24.57%-31.64%-16.94%
R&D--19.01M19.02M18.82M19.91M20.09M22.30M33.96M30.62M27.73M28.18M28.72M28.61M
R&D as % of Total Revenue--4.05%4.39%4.24%4.07%4.19%4.54%3.17%5.81%5.08%4.70%4.77%4.76%
Interest Expense9.67M11.43M9.88M9.03M8.04M7.61M7.11M6.66M7.71M12.04M20.68M23.19M26.43M21.73M
Interest Expense % of Total Revenue2.28%2.24%2.10%2.08%1.81%1.56%1.48%1.35%0.72%2.28%3.79%3.86%4.39%3.62%

Balance Sheet

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets379.79M373.35M437.01M473.37M516.55M822.96M845.81M869.60M1.07B1.24B1.46B1.28B1.06B927.94M
Total Liabilities258.41M204.78M226.10M250.86M259.87M285.40M285.78M302.08M371.84M580.29M835.75M803.11M772.14M746.77M
Total Equity121.38M168.57M209.46M220.84M252.96M531.81M556.73M564.16M696.79M649.78M616.66M469.27M279.29M177.19M
Cash79.06M50.30M66.09M78.69M97.83M268.33M238.36M193.67M325.21M152.82M127.82M95.67M50.00M25.86M
Total Debt140.00M151.00M156.00M174.00M153.00M156.00M156.00M142.00M177.62M353.80M473.50M452.45M473.06M-
Net Debt60.94M100.70M89.91M95.31M55.17M-112.33M-82.36M-51.67M-147.59M200.98M345.68M356.78M423.06M392.92M

Cash Flow

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow76.07M20.14M73.52M90.66M99.35M49.24M52.75M32.99M154.12M-84.25M31.28M15.51M63.32M47.73M
Investing Cash Flow-19.71M-28.73M-13.01M-44.02M-50.52M-91.48M-73.50M-25.95M-76.21M-225.38M-181.42M-16.35M-25.14M-
Financing Cash Flow-13.70M-322.27K-44.64M-43.88M-37.36M216.81M-21.47M-41.37M59.25M124.68M125.53M-57.71M-42.19M-
Capital Expenditure21.36M28.81M6.94M44.30M54.03M31.14M77.76M56.36M123.29M211.75M146.16M66.16M32.41M13.20M
Free Cash Flow54.72M-8.67M66.58M46.37M45.32M18.10M-25.01M-23.37M30.83M-296.01M-114.88M-50.65M30.92M34.53M
Dividends Paid78.70M10.60M20.15M53.08M13.84M46.59M21.47M20.80M8.45M33.78M18.60M21.63M27.08M25.90M
FCF to OCF71.93%-43.02%90.56%51.14%45.61%36.76%-47.41%-70.82%20.00%351.33%-367.30%-326.57%48.82%72.35%
Dividend Paid to FCF143.84%-122.29%30.27%114.48%30.54%257.38%-85.83%-89.01%27.41%-11.41%-16.19%-42.71%87.59%75.01%

Earnings

Report DateSep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jul 15, 2020Oct 23, 2020Dec 31, 2020Apr 30, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate-----------------------
EPS Actual0.050.020.040.090.05-0.050.030.050.04-0.020.030.340.040.020.040.010.01-0.130.020.000.00-0.080.02
Surprise-----------------------
Timing-----------------------

Key Statistics & Ratios

Market Cap2.44B
Enterprise Value3.06B
Trailing P/E0.00
Forward P/E0.00
Price / Sales4.32
Price / Book16.86
EPS-0.37
Book Value0.551
Revenue (TTM)565.28M
Gross Profit (TTM)11.76M
EBITDA-35.90M
Profit Margin-18.85%
Operating Margin-7.47%
Return on Equity-48.64%
Return on Assets-5.69%
Shares Outstanding289.04M
Shares Float136.41M
Beta0.43
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20211×
0.12May 21, 2021
20201×
0.04Jun 12, 2020
20191×
0.07May 14, 2019
20181×
0.05Jun 21, 2018

Stock Splits

  • May 21, 20211.3:1
  • Jun 12, 20201.3:1
  • May 14, 20191.3:1
  • Jun 21, 20181.3:1